The Oncology Institute, Inc. (TOI) Stock Analysis — Probabli.AI
AI-powered analysis for TOI (The Oncology Institute, Inc.): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. Latest AI outlook: Bullish.
Last price: $3.59 · Market cap: $335.5M · AI outlook: Bullish
The Oncology Institute, Inc. (TOI) demonstrates strong potential for significant market outperformance due to strategic partnerships, high revenue growth expectations, and expanding telehealth and R&D capabilities. While challenges including operational cost issues and regulatory delays persist, the positive forecasted drivers far outweigh potential setbacks. Given the analyst consensus and a…
Probabilistic 1-Year Outlook
- Bull 60% · Neutral 30% · Bear 10%
- 1-year price estimates — P10: $2 / P50: $6 / P90: $8
- The strong analyst consensus with a mean price target nearly double its current price suggests high upside potential. Positive headlines indicate operational growth and strategic expansions, supporting a bullish stance.…
5-Year Outlook
- Bull 70% · Neutral 20% · Bear 10%
- 5-year price estimates — P10: $4 / P50: $15 / P90: $25
SWOT Highlights
- Strength: High revenue growth projection.
- Strength: Strong strategic partnerships.
- Risk: High operational costs.
- Risk: Negative earnings surprises.
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
3 Wall Street analysts rate TOI a STRONG BUY with a mean price target of $6.67.
Last analyzed · Model: gpt-4o. How this forecast works · Accuracy & validation.
TOI forecast details · TOI sentiment details
Recent saved forecast research
AI-generated research records, not evaluated investment results.
- The Oncology Institute, Inc. (TOI) — saved
The Oncology Institute, Inc. (TOI) demonstrates strong potential for significant market outperformance due to strategic partnerships, high revenue growth expectations, and expanding telehealth and R&D capabilities. While challenges includin
- The Oncology Institute, Inc. (TOI) — saved
The Oncology Institute demonstrates substantial growth potential, bolstered by expansive revenue projections, analyst upgrades, and ongoing expansion efforts. While risks present in lawsuits and operational losses, the company is at the for
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.